Creative Planning’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Creative Planning's VKTX Position: Q3 2026 in Review
Creative Planning increased its Viking Therapeutics (VKTX) stake by 73% in Q3 2026, buying an estimated $932K and bringing the position to 63,931 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2153.
Creative Planning first reported a position in VKTX in Q3 2015 and has held it in 27 quarters since. 443 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Creative Planning held 63,931 shares of Viking Therapeutics worth $2.08M as of Q3 2026.
- Creative Planning bought 26,907 Viking Therapeutics shares in Q3 2026, an estimated $932K.
- Viking Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q3 2026, its #2153 holding.
- Creative Planning first reported a position in Viking Therapeutics in Q3 2015 and has held it in 27 quarters since.
- 443 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.